Gene · 2621
NIH grants2,018
NIH grants whose papers are about the gene, through NIH's grant-paper links.
701 to 720 of 2,018
Download this page as JSON| Grant | Title | GAS6 papers | Newest fiscal year |
|---|---|---|---|
| R01HL147357 | Cardiac Patches Loaded with Stem Cell Factors to Treat Heart Failure | 1 | 2022 |
| R01HL148050 | Clonal hematopoiesis in humans: determinants of development and progression | 1 | 2022 |
| R01HL149302 | Pro-inflammatory activation of human macrophages regulated by lncRNAs | 1 | 2022 |
| R01NS105741 | Establishing VEP as a quantitative biomarker for remyelination using transgenic models for gain and loss of function | 1 | 2022 |
| R01NS108034 | Elucidating cellular activity patterns underlying spinal cord function | 1 | 2022 |
| R03HL155041 | Deep phenotypic and functional characterization of salt-responsive immune cells in human salt senstive hypertension using CTE-seq | 1 | 2022 |
| R15HD108743 | Receptor for advanced glycation end-products signaling induction in the lung and placenta due to secondhand smoke and e-cigarette vapor | 1 | 2022 |
| R21AI163708 | Biophysical characterization of SARS-CoV-2 spike protein - receptor interactions | 1 | 2022 |
| R21AI163924 | Functional characterization of SARS-CoV-2 myeloid cell receptors as an immunopathogenic mechanisms of COVID-19 | 1 | 2022 |
| R21DE031072 | RNA modification and the regulation of partial EMT in head and neck cancer | 1 | 2022 |
| R21EY033188 | Anti-inflammatory role of MerTK in the RPE independent of diurnal outer segment phagocytosis | 1 | 2022 |
| R21HD104071 | A new animal model for investigating the invasive trophoblast lineage | 1 | 2022 |
| R44NS108869 | Generation of Tissue Engineered Nerve Grafts from GalSafe Porcine Neurons | 1 | 2022 |
| R56AG068026 | Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics | 1 | 2022 |
| T32AI007508 | Experimental Immunology Training Grant | 1 | 2022 |
| T32AI055432 | Global Biothreats Training Program | 1 | 2022 |
| T32AR007611 | Postdoctoral Rheumatology Training | 1 | 2022 |
| T32CA117846 | Pathways to Cancer Therapeutics | 1 | 2022 |
| T32DC000022 | Development of Clinician/Researchers in Academic ENT | 1 | 2022 |
| T32DK007199 | Research Training in Nephrology | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/grants?page=36